Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trials.

Ullah I, Tayyaba Rehan S, Khan Z, Hasan Shuja S, Hamza Shuja M, Irfan M, Gonuguntla K, Chadi Alraies M, Aggarwal P, Raina S, Sattar Y, Sohaib Asghar M

Open source

DOI: 10.1016/j.ijcha.2024.101467
Published: 2024 Aug
Container: International journal of cardiology. Heart & vasculature
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijcha.2024.101467,
  title = {Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trials.},
  author = {Ullah I and Tayyaba Rehan S and Khan Z and Hasan Shuja S and Hamza Shuja M and Irfan M and Gonuguntla K and Chadi Alraies M and Aggarwal P and Raina S and Sattar Y and Sohaib Asghar M},
  year = {2024},
  journal = {International journal of cardiology. Heart \& vasculature},
  doi = {10.1016/j.ijcha.2024.101467},
  url = {https://doi.org/10.1016/j.ijcha.2024.101467}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trials.
AU  - Ullah I
AU  - Tayyaba Rehan S
AU  - Khan Z
AU  - Hasan Shuja S
AU  - Hamza Shuja M
AU  - Irfan M
AU  - Gonuguntla K
AU  - Chadi Alraies M
AU  - Aggarwal P
AU  - Raina S
AU  - Sattar Y
AU  - Sohaib Asghar M
PY  - 2024
JO  - International journal of cardiology. Heart & vasculature
DO  - 10.1016/j.ijcha.2024.101467
UR  - https://doi.org/10.1016/j.ijcha.2024.101467
ER  -

APA

I, U., S, T. R., Z, K., S, H. S., M, H. S., M, I., K, G., M, C. A., P, A., S, R., Y, S., & M, S. A. (2024). Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy - an updated Meta-Analysis of randomized controlled trials.. International journal of cardiology. Heart & vasculature. https://doi.org/10.1016/j.ijcha.2024.101467

Source records

pubmed · retrieved 2026-09-25T16:23:05.182Z
europe-pmc · retrieved 2026-09-25T16:23:05.182Z
doaj · retrieved 2026-09-25T16:23:05.176Z